Skip to main content

Table 2 Clinical data of training and validation data set in non-elderly patients with common bile duct stones

From: Prediction for post-ERCP pancreatitis in non-elderly patients with common bile duct stones: a cross-sectional study at a major Chinese tertiary hospital (2015–2023)

Variables

Training set (N = 736)

Validation set (N = 183)

\({\chi }^{2}\)/t

p

Gender (Male/ female)

323/413

76/107

0.331

0.565

HBP (NO / YES)

611/125

147/36

0.733

0.392

DM (NO / YES)

682/54

169/14

0.021

0.885

History of pancreatitis (NO / YES)

696/40

167/16

2.803

0.094

History of hepatitis (NO / YES)

717/19

179/4

0.002

0.966

Presence of the gallbladder (NO / YES)

427/309

111/72

0.421

0.517

With gallstone (NO / YES)

511/225

139/44

3.016

0.082

Number of Stones (1 / 2 / multiple)

383/58/295

108/11/64

2.997

0.223

Type of duodenal papillae (papillary / other)

703/33

175/8

0.004

0.948

Difficult cannulation (NO / YES)

675/61

168/15

0.002

0.968

EST (NO / YES)

436/300

109/74

0.006

0.936

EPBD (NO / YES)

173/563

39/144

0.398

0.528

Age (year)

46.67 ± 10.69

46.34 ± 10.37

0.371

0.711

Hb (g/L)

130.52 ± 16.45

129.87 ± 17.55

0.466

0.641

PLT (109/L)

211.60 ± 75.87

210.30 ± 70.00

0.211

0.833

N (%)

59.58 ± 11.71

59.85 ± 12.67

0.277

0.781

TB (umol / L)

35.44 ± 45.90

33.85 ± 46.42

0.418

0.676

AST (IU / L)

92.11 ± 131.53

105.30 ± 169.03

0.984

0.326

ALP (IU / L)

178.70 ± 146.88

190.39 ± 169.83

0.933

0.351

ALB (g / L)

42.22 ± 4.12

42.28 ± 4.15

0.196

0.844

Diameter of common bile duct

10.11 ± 4.29

10.23 ± 4.20

0.346

0.730

Diameter of stone

7.23 ± 3.19

7.32 ± 3.28

0.354

0.724

PEP (NO / YES)

697/39

174/9

0.043

0.836